Is there a role for voice therapy in the treatment of laryngopharyngeal reflux? A pilot study.

IF 2.1 4区医学 Q2 OTORHINOLARYNGOLOGY Acta Otorhinolaryngologica Italica Pub Date : 2024-02-01 DOI:10.14639/0392-100X-N2742

Maria Rosaria Barillari, Andrea Nacci, Luca Bastiani, Giuseppina Mirra, Giuseppe Costa, Antonino Maniaci, Ludovico Docimo, Salvatore Tolone, Federica Giumello, Fabrizio Minichilli, Carlos M Chiesa Estomba, Jerome R Lechien, Thomas L Carroll

{"title":"Is there a role for voice therapy in the treatment of laryngopharyngeal reflux? A pilot study.","authors":"Maria Rosaria Barillari, Andrea Nacci, Luca Bastiani, Giuseppina Mirra, Giuseppe Costa, Antonino Maniaci, Ludovico Docimo, Salvatore Tolone, Federica Giumello, Fabrizio Minichilli, Carlos M Chiesa Estomba, Jerome R Lechien, Thomas L Carroll","doi":"10.14639/0392-100X-N2742","DOIUrl":null,"url":null,"abstract":"Objective: The aim of this study was to compare the efficacy of voice therapy combined with standard anti-reflux therapy in reducing symptoms and signs of laryngopharyngeal reflux (LPR).Methods: A randomised clinical trial was conducted. Fifty-two patients with LPR diagnosed by 24 h multichannel intraluminal impedance-pH monitoring were randomly allocated in two groups: medical treatment (MT) and medical plus voice therapy (VT). Clinical symptoms and laryngeal signs were assessed at baseline and after 3 months of treatment with the Reflux Symptom Index (RSI), Reflux Finding Score (RFS), Voice Handicap Index (VHI) and GRBAS scales.Results: Groups had similar scores at baseline. At 3-month follow-up, a significant decrease in RSI and RFS total scores were found in both groups although it appeared to be more robust in the VT group. G and R scores of the GRBAS scale significantly improved after treatment in both groups, with better results in the VT group. The VHI total score at 3 months improved more in the VT group (VHI delta 9.54) than in the MT group (VHI delta 5.38) (p < 0.001).Conclusions: The addition of voice therapy to medications and diet appears to be more effective in improving treatment outcomes in subjects with LPR. Voice therapy warrants consideration in addition to medication and diet when treating patients with LPR.","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":"44 1","pages":"27-35"},"PeriodicalIF":2.1000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10914355/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Otorhinolaryngologica Italica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14639/0392-100X-N2742","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: The aim of this study was to compare the efficacy of voice therapy combined with standard anti-reflux therapy in reducing symptoms and signs of laryngopharyngeal reflux (LPR).

Methods: A randomised clinical trial was conducted. Fifty-two patients with LPR diagnosed by 24 h multichannel intraluminal impedance-pH monitoring were randomly allocated in two groups: medical treatment (MT) and medical plus voice therapy (VT). Clinical symptoms and laryngeal signs were assessed at baseline and after 3 months of treatment with the Reflux Symptom Index (RSI), Reflux Finding Score (RFS), Voice Handicap Index (VHI) and GRBAS scales.

Results: Groups had similar scores at baseline. At 3-month follow-up, a significant decrease in RSI and RFS total scores were found in both groups although it appeared to be more robust in the VT group. G and R scores of the GRBAS scale significantly improved after treatment in both groups, with better results in the VT group. The VHI total score at 3 months improved more in the VT group (VHI delta 9.54) than in the MT group (VHI delta 5.38) (p < 0.001).

Conclusions: The addition of voice therapy to medications and diet appears to be more effective in improving treatment outcomes in subjects with LPR. Voice therapy warrants consideration in addition to medication and diet when treating patients with LPR.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

嗓音疗法在治疗喉咽反流中发挥作用吗？一项试点研究。

研究目的本研究旨在比较嗓音疗法与标准抗反流疗法相结合对减轻喉咽反流（LPR）症状和体征的疗效：方法：进行了一项随机临床试验。52名通过24小时多通道腔内阻抗-pH监测确诊的LPR患者被随机分配到两组：药物治疗组（MT）和药物加嗓音治疗组（VT）。在基线和治疗 3 个月后，使用反流症状指数 (RSI)、反流发现评分 (RFS)、嗓音障碍指数 (VHI) 和 GRBAS 量表评估临床症状和喉部体征：各组基线得分相似。在 3 个月的随访中，两组的 RSI 和 RFS 总分均有显著下降，但 VT 组的下降幅度更大。两组的 GRBAS 量表 G 和 R 评分在治疗后都有明显改善，VT 组的效果更好。VT 组 3 个月时的 VHI 总分（VHI delta 9.54）比 MT 组（VHI delta 5.38）有更大改善（P < 0.001）：结论：在药物治疗和饮食治疗的基础上，嗓音治疗似乎能更有效地改善 LPR 患者的治疗效果。在治疗 LPR 患者时，除了药物治疗和饮食治疗外，还需要考虑嗓音治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Acta Otorhinolaryngologica Italica OTORHINOLARYNGOLOGY-

CiteScore

3.40

自引率

10.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Acta Otorhinolaryngologica Italica first appeared as “Annali di Laringologia Otologia e Faringologia” and was founded in 1901 by Giulio Masini. It is the official publication of the Italian Hospital Otology Association (A.O.O.I.) and, since 1976, also of the Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale (S.I.O.Ch.C.-F.). The journal publishes original articles (clinical trials, cohort studies, case-control studies, cross-sectional surveys, and diagnostic test assessments) of interest in the field of otorhinolaryngology as well as clinical techniques and technology (a short report of unique or original methods for surgical techniques, medical management or new devices or technology), editorials (including editorial guests – special contribution) and letters to the Editor-in-Chief. Articles concerning science investigations and well prepared systematic reviews (including meta-analyses) on themes related to basic science, clinical otorhinolaryngology and head and neck surgery have high priority.